Guardant Health, Inc. (GH)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$161.41+0.23%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · GH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 1,183.1 | 982.0 | 739.0 | 563.9 | 449.5 | 373.7 | 286.7 | 214.4 |
| Total Revenues | 1,183.1 | 982.0 | 739.0 | 563.9 | 449.5 | 373.7 | 286.7 | 214.4 |
| Cost of Revenues | 413.9 | 349.0 | — | 227.1 | — | — | — | — |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 375.8 | 364.2 | 347.8 | 367.2 | 373.8 | 263.2 | 149.9 | 86.3 |
| Operating Income | (470.3) | (437.2) | (443.6) | (564.7) | (544.4) | (411.0) | (255.0) | (82.4) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 3.9 | 2.6 | 2.6 | 2.6 | 2.6 | 4.8 | 1.2 |
| Interest & Investment Income | 38.8 | 34.1 | 53.7 | 35.4 | 6.1 | 3.9 | 10.2 | 13.7 |
| Net Interest Expenses | — | — | — | (32.8) | (3.5) | (1.4) | (5.4) | (12.6) |
| EBT, Incl. Unusual Items | (454.5) | (417.5) | (435.1) | (478.8) | (653.4) | (384.5) | (245.9) | (69.7) |
| Income Tax Expense | (1.0) | (1.3) | 1.3 | 0.7 | 1.1 | 0.3 | 0.4 | (1.9) |
| Net Income | ||||||||
| Net Income | (453.5) | (416.3) | (436.4) | (479.4) | (654.6) | (384.8) | (246.3) | (75.7) |
| Per Share | ||||||||
| Basic EPS | (3.41) | (3.32) | (3.56) | (4.28) | (6.41) | (4.00) | (2.60) | — |
| Diluted EPS | (3.41) | (3.32) | (3.56) | (4.28) | (6.41) | (4.00) | (2.60) | — |
| Revenue per Share | 8.90 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 132.9 | 125.4 | 122.7 | 112.0 | 102.2 | 101.3 | 97.5 | — |
| Diluted Weighted Avg Shares | 132.9 | 125.4 | 122.7 | 112.0 | 102.2 | 101.3 | 97.5 | — |
| Supplemental | ||||||||
| EBITDA | — | (397.5) | (401.2) | (521.8) | (508.4) | (388.7) | (238.9) | (71.0) |
| EBIT | (470.3) | (437.2) | (443.6) | (564.7) | (544.4) | (411.0) | (255.0) | (82.4) |
| Effective Tax Rate | 0.2% | — | — | -0.1% | -0.2% | -0.1% | -0.2% | 2.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.